is a member of the steering committee of PAVE and Think Brain Health
J Endocrinol Invest 47(11):26792690 Frias JP, Hsia S, Eyde S, Liu R, Ma X, Konig M, Kazda C, Mather KJ, Haupt A, Pratt E, Robins D (2023) Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
Because symptoms often vary from person to person, treatment usually works best when care is personalized and medically supervised
The step-wise dose increases exist to manage GI adaptation
Its primary mechanism is to accelerate cellular turnover at a dramatic rate
Unlike L-carnitine, acetyl-L-carnitine can pass the blood brain barrier